EZH2 Inhibitor EPZ-6438 Synergizes With Anti-Lymphoma Therapies In Preclinical Models
| Title: | EZH2 Inhibitor EPZ-6438 Synergizes With Anti-Lymphoma Therapies In Preclinical Models |
|---|---|
| Authors: | Johnston, L. Danielle, Knutson, Sarah, Warholic, Natalie, Klaus, Christine R, Wigle, Tim J., Iwanowicz, Dorothy, Littlefield, Bruce A., Scott, Margaret Porter, Smith, Jesse J, Moyer, Mikel P, Copeland, Robert A., Pollock, Roy M., Kuntz, Kevin W, Keilhack, Heike, Raimondi, Alejandra |
| Source: | In Blood 15 November 2013 122(21):4416-4416 |
| Database: | ScienceDirect |
| ISSN: | 00064971 |
|---|---|
| DOI: | 10.1182/blood.V122.21.4416.4416 |
| Published in: | Blood |
| Language: | English |